Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Treasury Shares (2018 - 2025)

Viemed Healthcare (VMD) has disclosed Treasury Shares for 6 consecutive years, with $2.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Treasury Shares rose 383.9% year-over-year to $2.1 million, compared with a TTM value of $2.1 million through Dec 2025, up 383.9%, and an annual FY2025 reading of $2.1 million, up 383.9% over the prior year.
  • Treasury Shares was $2.1 million for Q4 2025 at Viemed Healthcare, roughly flat from $2.1 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $2.2 million in Q1 2025 and bottomed at $219000.0 in Q3 2021.
  • Average Treasury Shares over 5 years is $936631.0, with a median of $620500.0 recorded in 2021.
  • Peak annual rise in Treasury Shares hit 383.9% in 2025, while the deepest fall reached 67.88% in 2025.
  • Year by year, Treasury Shares stood at $573000.0 in 2021, then dropped by 10.47% to $513000.0 in 2022, then decreased by 18.52% to $418000.0 in 2023, then rose by 5.5% to $441000.0 in 2024, then skyrocketed by 383.9% to $2.1 million in 2025.
  • Business Quant data shows Treasury Shares for VMD at $2.1 million in Q4 2025, $2.1 million in Q3 2025, and $494000.0 in Q2 2025.